S
John Shamsey
Senior director, managed markets strategy, Bristol-Myers Squibb
ACTIVE IN: Academy of Managed Care Pharmacy
USES: Longitudinal data to develop national account strategies
Medicare Part D had a significant impact on the industry, but John Shamsey, age 39, was ready for it. He had focused on managed markets early in his career, becoming versed in the intricacies of payers while his marketing colleagues considered the it an afterthought. As a result, Shamsey has become an unofficial spokesperson for Part D, explaining to colleagues in the company and the rest of the industry just how the whole thing works.
John Shamsey
"It gave me a chance to offer insight to others about what Medicare means to our current product portfolio, as well as for future products' value proposition development," says Shamsey. "The impact that managed markets and payers are having on our business will be really important for leaders to understand and to incorporate the perspective into the business."
The Weight-Loss Gold Rush: Legal and Regulatory Implications
July 11th 2024Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, what needs to be done for GLP-1s to be covered, advice for investors and financiers considering entering the weight-loss medication market and more.
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.